Soluble c5b-9 as a biomarker for complement activation in atypical hemolytic uremic syndrome

Am J Kidney Dis. 2015 Jun;65(6):968-9. doi: 10.1053/j.ajkd.2015.02.326. Epub 2015 Mar 25.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Atypical Hemolytic Uremic Syndrome / metabolism*
  • Biomarkers / metabolism
  • Case-Control Studies
  • Cohort Studies
  • Complement Activation
  • Complement Membrane Attack Complex / metabolism*
  • Enzyme-Linked Immunosorbent Assay
  • Female
  • Humans
  • Male
  • Predictive Value of Tests
  • Thrombocytopenia / metabolism
  • Young Adult

Substances

  • Biomarkers
  • Complement Membrane Attack Complex